NCT03535012

Brief Summary

Over the past 10 years, there have been substantial improvements in breast reconstruction by plastic surgeons, and much has been achieved in aesthetic restoration after mastectomy. Advances in both microsurgery and implants have allowed for a wider variety of surgical methods, and procedural skills that minimize donor site complications have been developed. With such satisfactory aesthetic results, interest has recently increased not only in breast reconstruction but also in sensory recovery. Due to the growing expectation of patients, sensory discomfort may decrease overall patient satisfaction with breast reconstruction despite good aesthetic results. Hence, for qualitative improvement of breast reconstruction surgery, efforts must be made to restore sensation in the reconstructed breast. There has been little research on the mechanism of sensory recovery despite its clinical importance. This study aimed to compare the degree of sensory recovery in the reconstructed breast using various reconstruction methods as well as to evaluate the status of neural regeneration with harvesting the tissues when nipple reconstruction is performed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

May 11, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 24, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2020

Completed
Last Updated

May 25, 2018

Status Verified

May 1, 2018

Enrollment Period

3.5 years

First QC Date

May 11, 2018

Last Update Submit

May 23, 2018

Conditions

Outcome Measures

Primary Outcomes (4)

  • Sensory recovery in the reconstructed breast according to reconstructive options

    Subjects will be followed up with quantitative sensory testing at 3 months (±1 month) after immediate breast reconstruction surgery.

    3 months (±1 month) after immediate breast reconstruction surgery

  • Sensory recovery in the reconstructed breast according to reconstructive options

    Subjects will be followed up with quantitative sensory testing at 6 months (±1 month) after immediate breast reconstruction surgery.

    6 months (±1 month) after immediate breast reconstruction surgery

  • Sensory recovery in the reconstructed breast according to reconstructive options

    Subjects will be followed up with quantitative sensory testing at 12 months (±2 months) after immediate breast reconstruction surgery.

    12 months (±2 months) after immediate breast reconstruction surgery

  • Sensory recovery in the reconstructed breast according to reconstructive options

    Subjects will be followed up with quantitative sensory testing at 18 months (±2 months) after immediate breast reconstruction surgery.

    18 months (±2 months) after immediate breast reconstruction surgery

Study Arms (2)

Reconstruction using an implant

Immediate 2 stage implant based breast reconstruction after mastectomy. All expanders are placed in the subpectoralis muscle using ADM as a sling. After expansion of the tissue expander change to the permanent implant is performed.

Reconstruction using abdominal tissue

immediate free DIEP flap breast reconstruction after mastectomy. DIEP(deep inferior epigastric perforator) free flap was prepared and transferred to the breast pocket. Microanastomosis was done under the microscopic magnification. On sitting position, free flap was inset into breast pocket with confirming of satisfactory inflammatory fold.

Eligibility Criteria

Age20 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This study will be conducted by dividing the subjects into two groups(25 per each arm) according to the method of reconstruction: implant vs. abdominal tissue. It is difficult to determine a sample size that can establish statistical significance based on previous studies. Therefore, the number of targeted subjects was estimated based on the number of patients that can generally be recruited during the study period.

You may qualify if:

  • Female adults over 20 years of age
  • Patients who have undergone or plan to undergo total mastectomy and immediate breast reconstruction after the diagnosis of breast cancer (including carcinoma in situ)
  • written consent to study participation

You may not qualify if:

  • presence of neuropathy that may hinder accurate assessment of sensation
  • presence of dermatological condition that may hinder accurate assessment of sensation
  • inability to provide written consent
  • decided by the research team to be unsuitable for this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Plastic Surgery, Yonsei University School of Medicine, Severance Hospital

Seoul, 03722, South Korea

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

A sample of 5 mm3 including skin tissue from the flap for reconstruction at the time of immediate breast reconstruction A sample of 5 mm3 including skin tissue at the time of nipple reconstruction (nipple reconstruction will be performed at the time requested by the subject)

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2018

First Posted

May 24, 2018

Study Start

September 1, 2016

Primary Completion

February 28, 2020

Study Completion

February 28, 2020

Last Updated

May 25, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations